AHEAD OF PRINT

Volume 51 (2024): Issue 1 (March 2024)

Volume 50 (2023): Issue 4 (December 2023)

Volume 50 (2023): Issue 3 (September 2023)

Volume 50 (2023): Issue 2 (June 2023)

Volume 50 (2023): Issue 1 (March 2023)

Volume 49 (2022): Issue 4 (December 2022)

Volume 49 (2022): Issue 3 (October 2022)

Volume 49 (2022): Issue 2 (June 2022)

Volume 49 (2022): Issue 1 (April 2022)

Volume 48 (2021): Issue 4 (November 2021)

Volume 48 (2021): Issue 3 (October 2021)

Volume 48 (2021): Issue 2 (July 2021)

Volume 48 (2021): Issue 1 (April 2021)

Volume 47 (2020): Issue 4 (November 2020)

Volume 47 (2020): Issue 3 (September 2020)

Volume 47 (2020): Issue 2 (July 2020)

Volume 47 (2020): Issue 1 (May 2020)

Volume 46 (2019): Issue 3 (October 2019)

Volume 46 (2019): Issue 2 (May 2019)

Volume 46 (2019): Issue 1 (February 2019)

Volume 45 (2018): Issue 2 (December 2018)

Volume 45 (2018): Issue 1 (March 2018)

Volume 44 (2017): Issue 2 (October 2017)

Volume 44 (2017): Issue 1 (May 2017)

Volume 43 (2016): Issue 2 (October 2016)

Volume 43 (2016): Issue 1 (March 2016)

Volume 42 (2015): Issue 2 (November 2015)

Volume 42 (2015): Issue 1 (May 2015)

Volume 41 (2014): Issue 2 (December 2014)

Volume 41 (2014): Issue 1 (June 2014)

Acta Medica Bulgarica

 The Journal Acta Medica Bulgarica is the official scientific medical journal of the Medical University – Sofia. It has been published since 1973 year by the Central Medical Library, which is part of the university. The Medical University of Sofia is the oldest medical university in Bulgaria and achieved a good international ranking.   The journal Acta Medica Bulgarica accepts original research articles, clinical practice and scientific reviews and case reports in all areas of medicine. Some but not all of the areas covered by the journal are:health policy, oncology, public health, general and internal medicine, diabetes and endocrinology, cardiology, neurology, surgery, infectious diseases, emergency medicine, obesity and nutrition, pharmacology and many others.   Since first published online in 2014, the Journal Acta Medica Bulgarica has been subject of increasing interest. Our highly committed editorial board provided guidance on how to make the journal a trustful source of health-related research, turning it into a high-quality open access medical journal. The great team behind the journal - our associate editors, digital editor, and assistant editors, are also the people behind the progress of the journal and their work resulted in a continuous and steady increasing of the citation rates.   The peer review policy of the Journal Acta Medica Bulgarica is in fact a single-blinded peer review. After submitting a manuscript, it takes four to eight weeks until the review process is completed. The median peer review turnaround is 8-12 weeks. The rejection rate of the Journal is 50% for 2020 year. The time from receipt to acceptance for the majority of articles is 8-12 weeks. The time from acceptance to publication is from 4 weeks to 18 months. About 10-20% of the articles are rejected on submission, not reaching peer-review, due to major issues such as a poor English language or lack of compliance with the Journal’s Instructions to Authors.   The Journal is published quarterly and the four issues per year are printed at three-months intervals. Each month between 10 and 20 articles are submitted for evaluation, the approximate number of submitted papers for 2020 was 180 manuscripts, of which 70-80% original research articles; the remaining being case reports and review articles.   We hope that the journal will keep on improving its scientific quality, gaining international recognition among physicians and scientists from all medical fields in Bulgaria and around the world.   The email address for authors to submit their papers is d.garlichkova@cml.mu-sofia.bg. To the attention of Diana Garclichkova.     Conflict of Interest Declaration and Author Agreement Form   It is the policy of the Journal Acta Medica Bulgarica to ensure objectivity and scientific rigor in the Journal. All authors are expected to disclose to the readers any conflict(s) of interest such as relationships with pharmaceutical companies, biomedical device manufacturers, etc.Any potential conflict should be identified openly so that the readers may form their own judgements about the article with the full disclosure of the facts.   All Authors should have seen and approved the manuscript being submitted. The article should be the Authors' original work. The article should not be published elsewhere and should not be under consideration for publication elsewhere. On behalf of all Co-Authors, the corresponding Author shall bear full responsibility for the submission.   Polices on Animal &amp; Human Rights   Acta Medica Bulgarica Journal has formulated policies to ensure protection and proper use of animals and human in all forms of research. Researchers should have a moral obligation towards the animals and human subjects they use for their research goals and they must treat them with compassion and consider their well-being while designing the projects.All research articles that include human subjects should be performed in accordance to the World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects last edited October, 2013.All research studies that use animal models should be performed in accordance with “the Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals’, Washington DC, National Academy Press.All relevant information, including approval of the Local Ethics Committee, written informed consent information and ethical standards that the authors adhered to, should be clearly stated in the “Materials and Methods”section. The authors involved in research and experiments involving human subjects must confirm that informed consent was obtained from all participants and/or their legal guardians.   Peer Review Process   The PEER REVIEW politics of the Journal Acta Medica Bulgarica is a single-blind peer review.After submitting a manuscript, the review process takes 6-8 weeks.The median peer review turnaround is 8-12 weeks.The time from acceptance of an article to its actual publication is from 4 weeks to 12-18 months.   The journal does not have article processing charges (APCs) nor article submission charges.   Rejection rate:    70%      Archiving   Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.   Plagiarism Policy   The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 

Acta Medica Bulgarica

AHEAD OF PRINT

Wyszukiwanie

Wszystkie tomy i zeszyty w tym czasopiśmie